Apriligen
Pre-clinicalDedicated to curing rare pediatric diseases caused by the failure of a single gene beginning with our first clinical gene therapy program, APR-2020 – a purpose built lentiviral vector to treat RPS-19 Deficient Diamond Blackfan Anemia (“DBA”).
Founded
2021
Focus
Viral Technology
About
Dedicated to curing rare pediatric diseases caused by the failure of a single gene beginning with our first clinical gene therapy program, APR-2020 – a purpose built lentiviral vector to treat RPS-19 Deficient Diamond Blackfan Anemia (“DBA”).
Company Info
TypePrivate
Founded2021
LocationSan Diego, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile